Center-Authored Papers

Filters: Author is Anzala, Omu  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
M
McClelland SR, Balkus JE, Lee J, Anzala O, Kimani J, Schwebke J, Bragg V, Lensing S, Kavak L.  2014.  Randomized Trial of Periodic Presumptive Treatment with High-Dose Intravaginal Metronidazole and Miconazole to Prevent Vaginal Infections in HIV-negative Women.. The Journal of infectious diseases. Abstract
B
Barouch DH, Kik SV, Weverling GJ, Dilan R, King SL, Maxfield LF, Clark S, Ng'ang'a D, Brandariz KL, Abbink P et al..  2011.  International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations.. Vaccine. 29(32):5203-9. Abstract
Balkus JE, Manhart LE, Lee J, Anzala O, Kimani J, Schwebke J, Shafi J, Rivers C, Kabare E, McClelland SR.  2016.  Periodic presumptive treatment for vaginal infections may reduce the incidence of bacterial sexually transmitted infections.. The Journal of infectious diseases. 213(12):1932-1937. Abstract
Balkus JE, Srinivasan S, Anzala O, Kimani J, Andac C, Schwebke J, Fredricks DN, McClelland SR.  2017.  Impact of Periodic Presumptive Treatment for Bacterial Vaginosis on the Vaginal Microbiome among Women Participating in the Preventing Vaginal Infections Trial.. The Journal of infectious diseases. 215(5):723-731. Abstract
Baden LR, Karita E, Mutua G, Bekker L-G, Gray G, Page-Shipp L, Walsh SR, Nyombayire J, Anzala O, Roux S et al..  2016.  Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial.. Annals of internal medicine. Abstract